. Author manuscript; available in PMC: 2022 Nov 1.

Published in final edited form as: Transplant Cell Ther. 2021 Aug 8;27(11):937.e1–937.e7. doi: 10.1016/j.jtct.2021.08.001

Table III:

Multivariable Cox Proportional Hazards Models

Model	Predictor	HR (95% CI)	p-value
NMSC
	Age at Transplant
	By Quartile	1.94 (1.23, 3.06)	0.0047
	C-Reactive Protein
	Quartile 1	1.00 (REF)	0.029
	Quartiles 2–4	9.49 (1.26, 71.58)	0.029
	GI cGVHD
	No	1.00 (REF)	0.017
	Yes	0.26 (0.09, 0.78)	0.017

Cancer other than NMSC
	T-Cell Depletion
	No	1.00 (REF)	0.023
	Yes	3.09 (1.17, 8.20)	0.023
	Lymphoma Indication
	No	1.00 (REF)	0.0038
	Yes	0.25 (0.10, 0.64)	0.0038
	Oral cGVHD
	None/Mild	1.00 (REF)	0.0061
	Moderate/Severe	4.36 (1.52, 12.46)	0.0061

Quartiles of age: Q1: 25, Q2: 43, Q3: 51; Quartile of CRP used in the model: Q1: 0.55 mg/L